Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets
Patented Tech Easily Transforms Distillate into “Free flow” Powder Matrix
PHILADELPHIA, Sept. 20, 2022 /PRNewswire/ — Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF)
, a global leader in the resea…